Quality of life in patients with chronic myeloid leukemia in deep molecular response before and after tyrosine kinase inhibitors treatment discontinuation
Автор: Anna N. Petrova, Tatyana I. Ionova, Ekaterina Yu. Chelysheva, Oleg A. Shukhov, Anastasiya V. Bykova, Irina S. Nemchenko, Tatiana P. Nikitina, Natalia M. Porfirieva, Anna V. Zinkovskaya, Nikolay N. Tsyba, Anna G. Turkina
Журнал: Вестник гематологии @bulletin-of-hematology
Рубрика: Оригинальные статьи
Статья в выпуске: 1 т.17, 2021 года.
Бесплатный доступ
We aimed to study the quality of life (QoL) in chronic myeloid leukemia (CML) patients with deep molecular response (DMR) before and after tyrosine kinase inhibitors (TKIs) discontinuation
Сhronic myeloid leukemia, deep molecular response, tyrosine kinase inhibitors, treatment-free remission, quality of life
Короткий адрес: https://sciup.org/170175041
IDR: 170175041
Статья научная
